Articles
press release - PR NewsChannelHave you seen the NEW PR NewsChannel?
PR NewsChannel, the press release distribution company.

Home | Client Login | Company News | About Us | Contact Us | Blog: PR How To

PR NewsChannels

 Send Release

 Pricing

 PR Writing

Find

Need Assistance?
Contact us @ 888.399.5534

Latisse Leads to Lush, Full Lashes Says Tampa Dermatologist

Dr. Seth Forman says his patients are seeing success with the lash growth medication and talks about the product to Glamour magazine.

Like this story? Share it: Bookmark and Share


PR NewsChannel) / February 23, 2010 / Tampa, Fla. / Dr. Seth Forman says if you're looking for long, luscious eyelashes you may want to try Latisse. The Tampa dermatologist says he prescribes it to his patients and sees success. Glamour magazine quoted Dr. Forman about how well the eyelash growth medication works.

"There have been concerns with eyelid discoloration, but I haven't seen that" says the Tampa dermatologist. "If patients follow the directions, they shouldn’t have any problems."

Dr. Forman says Latisse is FDA approved and if used properly, will stimulate eyelash growth in 12 weeks. He adds there are several over-the-counter products that make the same claim, but do not work as well.

"Eyelashes are important to women," says the Tampa dermatologist. "Women spend billions of dollars each year on fake lashes, mascaras and other lash products. Latisse offers a more permanent solution to their lash problems."

Dr. Forman stresses that Latisse is for use on eyelashes only. "I have a patient who used the medication on her eyebrows with success, but I can't recommend others do that," he says. "Latisse is only FDA approved for eyelash use."

Latisse was discovered by accident says Dr. Forman. The product has the same formula as Lumigan, an eye drop made to treat glaucoma. The drug is categorized as a prostaglandin analog, which reduces pressure on the eyeball. The side effect was that it made patients' eyelashes longer and fuller.

Dr. Forman says, as with any medication, you should consult a physician before using Latisse. For more on Tampa dermatology or Dr. Seth Forman, please visit www.formanderm.com.

Media Contacts:
Justin Herndon
PR Firm: The Publicity Agency
Email: 
justin@thepublicityagency.com
Phone: (813) 708-1220 x7778 or (813) 528-6815
Web site:
www.thepublicityagency.com

Kimberly Polacek
PR Firm: The Publicity Agency
Email: 
kpolacek@seligmultimedia.com
Phone: (813) 708-1220 x 7780
Web site:
www.thepublicityagency.com


Permalink:


SOURCE: formanderm.com

Like this story? Share it: Bookmark and Share

PLEASE NOTE: To voice your opinion, please use the comment forms below. The above article is a press release. Find out how you can send a press release about your company, new product or newsworthy event.

For PR tips and to engage in conversation:
Follow
PR NewsChannel on Twitter.

Text size: Decrease Text Size Increase Text Size




Search PRNewsChannel:

Network with PRNewsChannel
press release distribution serviceTwitter
PR distribution serviceFacebook
press release servicesLinkedin
rss feeds press releases distributionFeeds
New Website!
Check out the NEW look of PR NewsChannel!
About This Press Release
For questions regarding information contained in this press release, please contact the company source listed in the press release. Please do not contact PRNewsChannel as we won't be able to provide assistance with your inquiry.
Copyright Notice
You do not need permission to link to pages on this site. Press releases on this site may be used for any legitimate media purpose. However, using the press releases from PRNewsChannel for distribution on competing press release distribution sites is prohibited.

PRNewsChannel.com: Legal | Client List | Contact Us | RSS Feeds | Careers
Recommended Sites: Publicity Agency | Press Release Pros
This is a press release distributed by PR NewsChannel. Contact us to learn more about press release distribution and how to get your news delivered to thousands of targeted news outlets.
Toll Free in U.S.: 888.399.5534 or 813.948.PROS (7767)
Copyright © PR NewsChannel. A Selig Multimedia, Inc. Company. All rights reserved.